Skip to main content

Full Schedule

Full Schedule

  • Wednesday, March 9, 2022
  • 9:00 AM – 11:15 AM
    I - Session I: Renal Cell Cancer

    Speaker: Hans Hammers, MD, PhD – UT Southwestern Medical Center

    Speaker: Pavlos Msaouel, MD, PhD – The University of Texas MD Anderson Cancer Center

    Speaker: Bradley McGregor, MD – Dana-Farber Cancer Institute; Harvard Medical School

    Speaker: Sumanta Pal, MD – City of Hope Comprehensive Cancer Center

  • 11:15 AM – 12:40 PM
    BREAK
  • 11:25 AM – 11:45 AM
    II - Session II: Selected Topics in Genitourinary Oncology 1
  • 11:25 AM – 12:40 PM
    II - Session II: Selected Topics in Genitourinary Oncology 1

    Speaker: Andrea B. Apolo, MD – Bethesda, MD

    Speaker: Andrea Necchi, MD – Università Vita-Salute San Raffaele / IRCCS San Raffaele Hospital

    Speaker: Philippe Spiess, MD – Moffitt Cancer Center

    Moderator: Petros Grivas, MD, PhD – University of Washington School of Medicine

  • 12:40 PM – 12:50 PM
    BREAK
  • 12:50 PM – 3:20 PM
    III - Session III: Urothelial Cancer

    Speaker: Andrea B. Apolo, MD – Bethesda, MD

    Speaker: Ali Raza Khaki, MD – Stanford University School of Medicine

    Speaker: Guru Sonpavde, MD – Dana-Farber Cancer Institute and Harvard Medical School

    Speaker: Jean H. Hoffman-Censits, MD – Greenberg Bladder Cancer Institute; Johns Hopkins Medicine

    Speaker: Alison J. Birtle, FRCP FRCR MD – Lancashire Teaching Hospitals

    Speaker: Peter H. O'Donnell, MD – The University of Chicago

    Speaker: Shilpa Gupta, MD – Taussig Cancer Institute, Cleveland Clinic Foundation

  • 3:20 PM – 3:30 PM
    BREAK
  • 3:30 PM – 4:25 PM
    IV - Session IV: Challenging Cases in Urothelial Cancer

    Moderator: Petros Grivas, MD, PhD – University of Washington School of Medicine

    Speaker: Shilpa Gupta, MD – Taussig Cancer Institute, Cleveland Clinic Foundation

    Speaker: Ali Raza Khaki, MD – Stanford University School of Medicine

  • Thursday, March 10, 2022
  • 8:45 AM – 10:05 AM
    V - Session V: Emerging Concepts in Urothelial Cancer

    Speaker: Andrea B. Apolo, MD – Bethesda, MD

    Speaker: Jason A. Efstathiou, MD, DPhil – Massachusetts General Hospital

    Speaker: Bishoy M. Faltas, MD – Weill Cornell Medicine

    Speaker: Pavlos Msaouel, MD, PhD – The University of Texas MD Anderson Cancer Center

  • 8:45 AM – 10:30 AM
    V - Session V: Emerging Concepts in Urothelial Cancer
  • 10:30 AM – 10:40 AM
    BREAK
  • 10:40 AM – 12:00 PM
    VI - Session VI: Targeted Therapies in Prostate Cancer I
  • 12:00 PM – 12:10 PM
    BREAK
  • 12:10 PM – 1:50 PM
    VII - Session VII: Targeted Therapies in Prostate Cancer II

    Speaker: Maha H. Hussain, MD, FACP, FASCO – Northwestern Medicine Feinberg School of Medicine

    Speaker: Tanya Dorff, MD – City of Hope

  • 1:50 PM – 2:00 PM
    BREAK
  • 2:00 PM – 2:35 PM
    Networking Room
  • 2:35 PM – 2:45 PM
    BREAK
  • 2:45 PM – 3:35 PM
    VIII - Session VIII: Selected Topics in Genitourinary Oncology 4

    Moderator: Alicia K. Morgans, MD, MPH – Dana-Farber Cancer Institute

    Speaker: Jessica E. Hawley, MD – University of Washington / Fred Hutch Cancer Research Center

    Speaker: Bradley McGregor, MD – Dana-Farber Cancer Institute; Harvard Medical School

    Speaker: Neha Vapiwala, MD, FACR, FASTRO – Penn Medicine, Hospital of the University of Pennsylvania

  • 3:35 PM – 5:00 PM
    IX - Session IX: Prostate Cancer Complications

    Speaker: Alicia K. Morgans, MD, MPH – Dana-Farber Cancer Institute

    Speaker: Neal Shore, MD,FACS – GenesisCare,US

    Speaker: Kosj Yamoah, MD, PhD – Moffitt Cancer Center

  • Friday, March 11, 2022
  • 9:30 AM – 11:10 AM
    X - Session X: Landscape Shift in mHSPC and nmCRPC

    Speaker: A. Oliver Sartor, MD – Tulane Cancer Center

    Speaker: Phuoc T. Tran, MD, PhD – University of Maryland School of Medicine

  • 11:10 AM – 11:20 AM
    BREAK
  • 11:20 AM – 12:55 PM
    XI - Session XI: Nuclear Medicine and Prostate Cancer

    Speaker: Thomas Hope, MD – University of California, San Francisco

    Speaker: A. Oliver Sartor, MD – Tulane Cancer Center

    Speaker: Neha Vapiwala, MD, FACR, FASTRO – Penn Medicine, Hospital of the University of Pennsylvania

  • 12:55 PM – 1:05 PM
    BREAK
  • 1:05 PM – 2:05 PM
    INNOVATION THEATER
  • 2:05 PM – 2:15 PM
    BREAK
  • 2:15 PM – 3:35 PM
    XII - Session XII: Systemic and Targeted Approaches for Treatment of nmCRPC

    Moderator: Alicia K. Morgans, MD, MPH – Dana-Farber Cancer Institute

    Speaker: Tanya Dorff, MD – City of Hope

    Speaker: Jessica E. Hawley, MD – University of Washington / Fred Hutch Cancer Research Center

    Speaker: Phuoc T. Tran, MD, PhD – University of Maryland School of Medicine

  • Wednesday, September 28, 2022
  • 9:30 AM – 11:50 AM
    I - Session I: Evolving Landscape of Non-Muscle Invasive Bladder Cancer (NMIBC) and Multidisciplinary Care for MIBC

    Moderator: Petros Grivas, MD, PhD – University of Washington School of Medicine

    Presenter: Carmen Mir, MD, PhD – IMED

    Presenter: Bishoy M. Faltas, MD – Weill Cornell Medicine

    Presenter: Ashish Kamat, MD, MBBS – MD Anderson Cancer Center

    Presenter: Ali Raza Khaki, MD – Stanford University School of Medicine

    Presenter: Emily Weg, MD – Department of Radiation Oncology, Fred Hutch Cancer Center / University of Washington

  • 11:50 AM – 12:00 PM
    Exhibit Hall
  • 12:00 PM – 1:00 PM
    Clinical Profile of a PARP inhibitor for the Treatment of mCRPC - Przemyslaw Twardowski, MD
  • 1:00 PM – 1:10 PM
    Exhibit Hall
  • 1:10 PM – 3:05 PM
    II - Session II: Practical considerations, standard of care and emerging biomarkers

    Moderator: Petros Grivas, MD, PhD – University of Washington School of Medicine

    Presenter: Philip Abbosh, MD-PhD – Fox Chase Cancer Center

    Presenter: Alison J. Birtle, FRCP FRCR MD – Lancashire Teaching Hospitals

    Presenter: Bishoy M. Faltas, MD – Weill Cornell Medicine

    Presenter: Matt Galsky, MD – Icahn School of Medicine at Mount Sinai

    Presenter: Shilpa Gupta, MD – Taussig Cancer Institute, Cleveland Clinic Foundation

    Presenter: Jean H. Hoffman-Censits, MD – Greenberg Bladder Cancer Institute; Johns Hopkins Medicine

  • 3:05 PM – 3:15 PM
    Exhibit Hall
  • 3:15 PM – 4:30 PM
    III - Session III: Current Strategies, Disparities, and Clinical Dilemmas in the Management of Bladder Cancer

    Moderator: Petros Grivas, MD, PhD – University of Washington School of Medicine

    Presenter: Philip Abbosh, MD-PhD – Fox Chase Cancer Center

    Presenter: Matt Galsky, MD – Icahn School of Medicine at Mount Sinai

    Presenter: Ali Raza Khaki, MD – Stanford University School of Medicine

    Presenter: Emily Weg, MD – Department of Radiation Oncology, Fred Hutch Cancer Center / University of Washington

  • Thursday, September 29, 2022
  • 9:40 AM – 11:50 AM
    IV - Session IV: RCC – Selected Topics in Genitourinary Oncology

    Moderator: Tian Zhang, MD, MHS – UT Southwestern Medical Center; Harold C. Simmons Comprehensive Cancer Center

    Presenter: Katy Beckermann, MD, PhD – Vanderbilt University Medical Center

    Presenter: Stephanie A. Berg, DO – Dana-Farber Cancer Institute , Lank Center for Genitourinary Oncology

    Presenter: Naomi B. Haas, MD – Abramson Cancer Center

    Presenter: Hans Hammers, MD, PhD – UT Southwestern Medical Center

    Presenter: Eric Jonasch – UT MD Anderson Cancer Center

    Presenter: Sumanta Pal, MD – City of Hope Comprehensive Cancer Center

  • 11:50 AM – 12:00 PM
    Exhibit Hall
  • 12:00 PM – 1:30 PM
    V - Session V: Targeted Therapies in Prostate Cancer I

    Moderator: Alicia K. Morgans, MD, MPH – Dana-Farber Cancer Institute

    Presenter: Pedro Barata, MD, MSc – Tulane University Medical School

    Presenter: Kim N. Chi, MD – BC Cancer, University of British Columbia

  • 12:00 PM – 1:30 PM
    VI - Session V: Targeted Therapies in Prostate Cancer I

    Moderator: Alicia K. Morgans, MD, MPH – Dana-Farber Cancer Institute

    Presenter: Pedro Barata, MD, MSc – Tulane University Medical School

    Presenter: Kim N. Chi, MD – BC Cancer, University of British Columbia

  • 1:30 PM – 1:40 PM
    Exhibit Hall
  • 1:40 PM – 3:10 PM
    VI - Session VI: Targeted Therapies in Prostate Cancer II

    Moderator: Alicia K. Morgans, MD, MPH – Dana-Farber Cancer Institute

    Presenter: Ana Aparicio, MD – The University of Texas MD Anderson Cancer Center

    Presenter: Karen Autio, MD, MSc – Memorial Sloan Kettering Cancer Center

    Presenter: Atish D. Choudhury, MD, PhD – Dana-Farber Cancer Institute

  • 1:40 PM – 3:10 PM
    VII - Session VI: Targeted Therapies in Prostate Cancer II

    Moderator: Alicia K. Morgans, MD, MPH – Dana-Farber Cancer Institute

    Presenter: Ana Aparicio, MD – The University of Texas MD Anderson Cancer Center

    Presenter: Karen Autio, MD, MSc – Memorial Sloan Kettering Cancer Center

    Presenter: Atish D. Choudhury, MD, PhD – Dana-Farber Cancer Institute

  • Friday, September 30, 2022
  • 9:30 AM – 12:00 PM
    VII - Session VII: Prostate Cancer Complications

    Moderator: Alicia K. Morgans, MD, MPH – Dana-Farber Cancer Institute

    Presenter: Asmaa El-Kenawi, PhD – Moffitt Cancer Center

    Presenter: Kelvin Moses, MD, PhD – Vanderbilt University Medical Center

    Presenter: Kerri M. Winters-Stone, PhD – Knight Cancer Institute, Oregon Health & Science University

  • 9:30 AM – 12:00 PM
    VIII - Session VII: Prostate Cancer Complications

    Moderator: Alicia K. Morgans, MD, MPH – Dana-Farber Cancer Institute

    Presenter: Asmaa El-Kenawi, PhD – Moffitt Cancer Center

    Presenter: Kelvin Moses, MD, PhD – Vanderbilt University Medical Center

    Presenter: Kerri M. Winters-Stone, PhD – Knight Cancer Institute, Oregon Health & Science University

  • 12:00 PM – 12:10 PM
    Exhibit Hall
  • 12:10 PM – 2:30 PM
    IX - Session VIII: Landscape Shift in mHSPC and nmCRPC

    Moderator: Alicia K. Morgans, MD, MPH – Dana-Farber Cancer Institute

    Presenter: Pedro Barata, MD, MSc – Tulane University Medical School

    Presenter: Kim N. Chi, MD – BC Cancer, University of British Columbia

    Presenter: Atish D. Choudhury, MD, PhD – Dana-Farber Cancer Institute

    Presenter: A. Oliver Sartor, MD – Tulane Cancer Center

    Presenter: David VanderWeele, MD PhD – Northwestern University

    Presenter: Neha Vapiwala, MD, FACR, FASTRO – Penn Medicine, Hospital of the University of Pennsylvania

  • 12:10 PM – 2:30 PM
    VIII - Session VIII: Landscape Shift in mHSPC and nmCRPC

    Moderator: Alicia K. Morgans, MD, MPH – Dana-Farber Cancer Institute

    Presenter: Pedro Barata, MD, MSc – Tulane University Medical School

    Presenter: Kim N. Chi, MD – BC Cancer, University of British Columbia

    Presenter: Atish D. Choudhury, MD, PhD – Dana-Farber Cancer Institute

    Presenter: A. Oliver Sartor, MD – Tulane Cancer Center

    Presenter: David VanderWeele, MD PhD – Northwestern University

    Presenter: Neha Vapiwala, MD, FACR, FASTRO – Penn Medicine, Hospital of the University of Pennsylvania

  • 2:30 PM – 2:40 PM
    Exhibit Hall
  • 2:40 PM – 4:15 PM
    X - Session IX: Nuclear Medicine and Prostate Cancer

    Moderator: Alicia K. Morgans, MD, MPH – Dana-Farber Cancer Institute

    Presenter: Phillip J. Koo, MD – Banner MD Anderson Cancer Center

    Presenter: A. Oliver Sartor, MD – Tulane Cancer Center

    Presenter: Neha Vapiwala, MD, FACR, FASTRO – Penn Medicine, Hospital of the University of Pennsylvania

  • 2:40 PM – 4:15 PM
    IX - Session IX: Nuclear Medicine and Prostate Cancer

    Moderator: Alicia K. Morgans, MD, MPH – Dana-Farber Cancer Institute

    Presenter: Phillip J. Koo, MD – Banner MD Anderson Cancer Center

    Presenter: A. Oliver Sartor, MD – Tulane Cancer Center

    Presenter: Neha Vapiwala, MD, FACR, FASTRO – Penn Medicine, Hospital of the University of Pennsylvania